BRONCHI-SHIELD ORAL is a unique Canine Infectious Respiratory Disease (CIRD) vaccine because it is the first live, avirulent Bordetella bronchiseptica vaccine licensed to be administered orally to dogs. BRONCHI-SHIELD ORAL offers the convenience of oral administration for mucosal absorption, making it one of the most innovative CIRD vaccines on the market. Plus, it is manufactured with BIVI’s PureFil™ Technology using the same thought processes and techniques found in Duramune®, Fel-O-Vax® and Fel-O-Guard® vaccines.
BRONCHI-SHIELD™ ORAL
Bordetella Bronchiseptica Vaccine
Avirulent Live Culture
For use in Dogs Only
This product has been shown to be effective for the vaccination of healthy dogs 8 weeks of age or older against Bordetella bronchiseptica. The duration of immunity for this product has not been established. For more information regarding the efficacy and safety data go to productdata.aphis.usda.gov.
Dosage and Administration: Rehydrate with the accompanying sterile diluent. Shake well and draw back into the syringe the required amount. Remove needle from syringe. Administer 1.0 mL orally in the buccal pouch. Use immediately.
The presence of maternal antibody is known to interfere with the development of active immunity in dogs and additional boosters will be required in most young animals. For advice on revaccination frequency and annual booster vaccinations, consultation with a veterinarian is recommended.
Proper oral administration
Caution: This product is designed for oral administration. Do not vaccinate dogs parenterally. Store in the dark at 2° to 8°C (35° to 46°F). Shake well after rehydration. Inactivate all unused contents before disposal. In case of anaphylactoid reaction, administer epinephrine. Do not mix with other products, except as specified on the label. This product has not been tested in pregnant animals. In case of human exposure, contact a physician.